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Abstract: Lipoprotein lipase (LPL) is a key rate-limiting enzyme for the hydrolysis of triacylglycerol
(TAG) in chylomicrons and very low-density lipoprotein. Given that postprandial assessment of
lipoprotein metabolism may provide a more physiological perspective of disturbances in lipoprotein
homeostasis compared to assessment in the fasting state, we have investigated the influence of two
commonly studied LPL polymorphisms (rs320, HindIII; rs328, S447X) on postprandial lipaemia, in
261 participants using a standard sequential meal challenge. S447 homozygotes had lower fasting
HDL-C (p = 0.015) and a trend for higher fasting TAG (p = 0.057) concentrations relative to the
447X allele carriers. In the postprandial state, there was an association of the S447X polymorphism
with postprandial TAG and glucose, where S447 homozygotes had 12% higher TAG area under the
curve (AUC) (p = 0.037), 8.4% higher glucose-AUC (p = 0.006) and 22% higher glucose-incremental
area under the curve (IAUC) (p = 0.042). A significant gene–gender interaction was observed for
fasting TAG (p = 0.004), TAG-AUC (Pinteraction = 0.004) and TAG-IAUC (Pinteraction = 0.016), where
associations were only evident in men. In conclusion, our study provides novel findings of an
effect of LPL S447X polymorphism on the postprandial glucose and gender-specific impact of the
polymorphism on fasting and postprandial TAG concentrations in response to sequential meal
challenge in healthy participants.
Keywords: lipoprotein lipase; sequential meals; postprandial study; triacylglycerol; glucose
1. Introduction
Large prospective cohort studies have identified elevated non-fasting triacylglycerol (TAG)
concentrations as an independent risk factor for cardiovascular disease (CVD) [1]. The Copenhagen
City Heart Study [2] and US Women’s Health Study [3] showed that non-fasting TAG concentrations
of ě5.0 mmol/L were associated with myocardial infarction and the Norwegian Counties Study [4]
showed that non-fasting TAG levels of >3.5 mmol/L were associated with a 5-fold increase in risk
of death from coronary heart disease. Endothelial associated Lipoprotein lipase (LPL) (E.C. 3.1.1.34)
plays an important role in the metabolism and clearance of triacylglycerol (TAG)-rich lipoproteins
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from the circulation [5] and atherogenesis, where it influences the interaction between atherogenic
lipoproteins and receptors on the vascular wall [6]. Hence, enzymes such as Lipoprotein lipase (LPL)
(E.C. 3.1.1.34) that regulate lipoprotein metabolism in the postprandial state [7] are of interest to the
prevention of CVDs.
Several polymorphisms in the LPL gene have been shown to lead to a reduction in enzyme
synthesis and activity and, to date, rs320 [HindIII (G/T)] and rs328 [Serine 447 Stop S447X (C/G)] have
been the most extensively studied. These variants with a prevalence of 40%–75% (rs320) and 17%–22%
(rs328) among Caucasians [8,9], respectively, have been shown to be associated with coronary artery
disease, myocardial infarction [10–12] and pronounced fasting hypertriacylglycerolemia [13,14]. Only
limited number of studies has examined their impact on postprandial lipaemia [15–17] and these
studies have used only a single test meal, which does not reflect the habitual eating pattern in humans.
Given that we spend nearly 75% of the time in a postprandial state, the normal physiological
pattern of meal intake and the impact of LPL gene polymorphisms on the clearance of dietary TAG
may be more evident after a sequential meal challenge. Hence, in the present study, we investigated
the association of the two commonly studied LPL polymorphisms [rs320 (HindIII) and rs328 (S447)]
with fasting and postprandial lipid concentrations by using a standard sequential meal challenge and
examined the penetrance of genotype according to gender, with gender previously shown to be a
modulator of the impact of other variants on postprandial TAG handling [18].
2. Results
The study participants included 153 men (mean ˘ SD, age 53 ˘ 10 years; BMI 27.3 ˘ 3.1 kg/m2)
and 109 women (mean ˘ SD, 52 ˘ 11 years; BMI 25.4 ˘ 3.5 kg/m2). The prevalence of S447
homozygotes was 81% (n = 213) versus 18% 447X minor allele carriers (n = 48). The frequency
of carriers of 447X in this study was consistent with published reports in Caucasian population [19].
56% of participants were homozygous for the H1 major allele for HindIII (n = 131) with 43% H2 minor
allele carriers (n = 100).
Table 1 describes the baseline characteristics of participants according to the S447X polymorphism.
There was a borderline genotype-related association with fasting serum TAG levels after adjusting
for age, gender, and BMI (p = 0.057). Circulating HDL-C concentrations were markedly lower in S447
homozygotes than 447X allele carriers (p = 0.015). None of the other fasting biochemical parameters
were significantly associated with S447X (Table 1) or HindIII polymorphisms (Supplementary Table S1)
(all p > 0.05).
A greater TAG AUC was observed in S447 allele homozygotes following the sequential meals
(p = 0.037). The area under the curve (AUC) and incremental area under the curve (IAUC) of the
glucose response was 8.4% (p = 0.006) and 22.6% (p = 0.042) lower in 447X allele carriers (p = 0.006),
respectively than common homozygotes. The postprandial summary measures did not show any
association with HindIII genotypes (Supplementary Table S1).
The S447X polymorphism showed a significant interaction with gender on fasting TAG (p = 0.004),
TAG AUC (p = 0.004) and TAG IAUC (p = 0.016) (Figure 1), with the major S447 allele homozygotes
at S447X in men showing higher values for fasting and postprandial TAG compared with X minor
allele carriers.
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Figure 1. (A) Mean (SEM) for fasting triacylglycerol (TAG) according to S447X polymorphism in men 
and women. Carriers of one or two copies of X minor allele are combined and presented by white 
bars. Gene–gender interaction was statistically significant for fasting TAG levels (Pinteraction = 0.031); (B) 
Mean (SEM) for the area under the curve (AUC) TAG response according to S447X polymorphism 
after consumption of a test breakfast (49 g fat) at 0 min and a test lunch (29 g fat) at 330 min. S447 
homozygotes (n = 213) had 12% higher TAG AUC (p = 0.037) compared to 447X carriers (n = 48) for 
men. Carriers of one or two copies of X minor allele are combined and presented by white bars. Gene–
Gender interaction was statistically significant for area under the TAG curve values (Pinteraction = 0.004); 
(C) Mean (SEM) for the incremental area under the curve (IAUC) TAG response according to S447X 
polymorphism after consumption of a test breakfast (49 g fat) at 0 min and a test lunch (29 g fat) at 
330 min in men, and women. Carriers of one or two copies of X minor allele are combined and 
presented by white bars. Gene–Gender interaction was statistically significant for IAUC TAG 
(Pinteraction = 0.016). 
Figure 1. (A) Mean (SEM) for fasting triacylglycerol (TAG) according to S447X polymorphism in men
and women. Carriers of one or two copies of X minor allele are combined and presented by white
bars. Gene–gender interaction was statistically significant for fasting TAG levels (Pinteraction = 0.031);
(B) Mean (SEM) for the area under the curve (AUC) TAG response according to S447X polymorphism
after consumption of a test breakfast (49 g fat) at 0 min and a test lunch (29 g fat) at 330 min. S447
homozygotes (n = 213) had 12% higher TAG AUC (p = 0.037) compared to 447X carriers (n = 48)
for men. Carriers of one or two copies of X minor allele are combined and presented by white
bars. Gene–Gender interaction was statistically significant for area under the TAG curve values
(Pinteraction = 0.004); (C) Mean (SEM) for the incremental area under the curve (IAUC) TAG response
according to S447X polymorphism after consumption of a test breakfast (49 g fat) at 0 min and a test
lunch (29 g fat) at 330 min in men, and women. Carriers of one or two copies of X minor allele are
combined and presented by white bars. Gene–Gender interaction was statistically significant for IAUC
TAG (Pinteraction = 0.016).
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Given the strong linkage disequilibrium between the two LPL polymorphisms [15], we also
examined the combined effects of the polymorphisms on baseline characteristics and postprandial
TAG and glucose. Nine possible genotype combinations were generated. However, given the
small sample size, only 3 combinations [S447S ´ H1/H1 (n = 131), S447S ´ H1/H2 (n = 55) and
S447X ´ H1/H2 (n = 45)] were available in our study participants. The frequencies of these three
genotype combinations are presented in the Supplementary Table S2. In the genotype-genotype
analysis, we found that individuals with the S447S genotype irrespective of HindIII alleles (i.e.,
SS/H1H1 and SS/ H1H2) had higher TAG AUC (p = 0.040) and glucose AUC (p = 0.034) levels than
447X allele carriers (Supplementary Table S3) suggesting that the associations are driven mainly by the
S447X polymorphism.
Table 1. Baseline and postprandial characteristics of the participants according to
LPL-S447X polymorphism.
Participant’s Characteristics S/S (n = 213) S/X (n = 48) Passociation
Age (years) 53 ˘ 11 52 ˘ 11 0.648
Men/Women 125/88 27/21 –
BMI (kg/m2) 26.3 ˘ 3.4 27.4 ˘ 3.2 0.015
Baseline Characteristics
TC (mmol/L) 5.78 ˘ 1.05 5.62 ˘ 1.00 0.285
TAG (mmol/L) 1.67 ˘ 0.90 1.48 ˘ 0.51 0.057
HDL-C (mmol/L) 1.29 ˘ 0.42 1.40 ˘ 0.33 0.015
LDL-C (mmol/L) 3.73 ˘ 1.02 3.53 ˘ 0.92 0.167
Glucose(mmol/L) 5.16 ˘ 0.66 5.14 ˘ 0.45 0.534
Insulin (pmol/L) 48.3 ˘ 31.2 50.3 ˘ 26.2 0.517
NEFA (µmol/L) 519 ˘ 184 477 ˘ 170 0.102
HOMA-IR 1.96 ˘ 1.40 1.99 ˘ 1.09 0.376
Postprandial summary measures
TAG AUC (mmol/L ˆ 480 min) 1193 ˘ 593 1046 ˘ 429 0.037
TAG IAUC (mmol/L ˆ 480 min) 353 ˘ 228 305 ˘ 210 0.149
NEFA AUC mmol/L ˆ 300 min 153 ˘ 45 149 ˘ 32 0.410
NEFA IAUC (mmol/L ˆ 300 min) 96 ˘ 39 100 ˘ 26 0.792
Glucose AUC (mmol/L ˆ 480 min) 3114 ˘ 460 2850 ˘ 763 0.006
Glucose IAUC (mmol/L ˆ 480 min) 595 ˘ 284 460 ˘ 238 0.042
Insulin AUC (nmol/L ˆ 480 min) 139 ˘ 94 123 ˘ 38 0.858
Insulin IAUC (nmol/L ˆ 480 min) 114 ˘ 89 100 ˘ 34 0.876
Values are mean˘ standard deviation. p-Values are from a linear model testing the association with LPL-S447X,
adjusted for age, gender, BMI; Abbreviations: TC, total cholesterol; TAG, triacylglycerol; HDL-C, high density
lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; NEFA, non-esterified fatty acids; HOMA-IR,
homeostasis model assessment—insulin resistance; For the baseline analysis, the insulin and HOMA-IR values
were available for 166 participants (men = 124, women = 42); For the postprandial analysis, the insulin AUC
and IAUC data was available for 79 participants (men = 68, women = 11).
3. Discussion
Our postprandial study using a standard sequential meal challenge demonstrates that individuals
homozygous for the common allele of the S447X polymorphism had significantly lower fasting HDL-C
levels and a significantly elevated postprandial TAG and glucose response relative to 447X allele
carriers. In addition, a gender-specific association between the S447X polymorphism and fasting and
postprandial TAG concentrations was observed, where the effect of the genotype was evident only
in men.
Several studies have demonstrated the association between S447 genotype and elevated fasting
plasma TAG levels and lower HDL-C levels [20,21]. Our study also has shown a borderline association
of the S447 allele with higher TAG and a significant association with lower HDL-C levels, which
is in accordance with a meta-analysis (n = 45,079) that showed 0.05 mmol/L lower HDL-C levels
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and 0.15 mmol/L higher TAG among the S447 homozygotes [12]. Furthermore, the association of
the S447 genotype with postprandial TAG in our study has also been confirmed in previous studies
(Supplementary Table S4). However, the mechanism by which this polymorphism affects lipid levels
still remains obscure. Functional studies have demonstrated that the 447X variant that results in a
2 amino acid truncation on the carboxyl-terminal domain of the LPL increases the ability of the cell
surface receptors to bind with TAG-lipoproteins [8]; but it is not clear how this truncation increases
the ability of LPL to bind TAG. While a few studies have reported that S447X polymorphism might
increase or decrease the LPL activity [22–24], some have failed to show a significant effect [23,25].
The probable mechanism by which LPL S447 allele lowers HDL-C could be related to higher TAG
concentrations. A delayed clearance of triglyceride-rich lipoproteins (TRLs) drives the transfer of TAG
from TRLs to both LDL and HDL by cholesteryl ester transfer protein (CETP), which makes them
suitable substrates for lipases. This leads to the formation of smaller denser HDL particles which are
rapidly removed from the circulation, thus decreasing HDL-C concentrations [26].
We also observed a novel association between LPL S447X polymorphism and postprandial
glucose using the sequential meal challenge, where S447 homozygotes had higher glucose AUC
and IAUC. Previous postprandial studies have shown higher postprandial glucose concentrations
in response to three meals [27,28]. Given that the postprandial studies examining the effects of
LPL polymorphisms have used only a single meal [15–17], it is possible that the effects of LPL
polymorphisms on postprandial glucose have been missed previously. One of the reasons for higher
postprandial glucose could be due to the decreased insulin sensitivity in the S447 homozygotes [29].
LPL has been considered as a link between insulin resistance and atherosclerosis, given its role in
controlling the delivery of free fatty acids to muscle, adipose tissue and vascular wall macrophages,
wherein lipid uptake influences insulin sensitivity [30]. It was also shown in the Quebec Family study
that the LPL markers (HindIII and S447X) combination influenced the insulin AUC during an oral
glucose tolerance test [31]. In our study, we did not find any association with fasting and postprandial
insulin and HOMA-IR, which might be due to limited power for this analysis as insulin concentrations
were not available for all participants (n < 166). However, given that low HDL cholesterol and high TAG
are frequently found with insulin resistance [32], it is possible that decreased insulin sensitivity could
be a possible mechanism for higher postprandial glucose concentrations in the S447 homozygotes.
This was also shown in a previous study where individuals with insulin resistance had elevated fasting
and postprandial TAG, and lower HDL-C levels [33].
Our results also demonstrated gender-specific effect of LPL S447X polymorphism on fasting and
postprandial TAG, where the association was significant only in men. The gender-specific effects
of other SNPs (LEPR [34], APOA5 [18] and APOB [35]) in men have already been shown in our
postprandial cohort which is characteristic of men with higher BMI, fasting TAG, insulin and lower
HDL-C than women irrespective of the genotype. A postprandial study in 63 men also showed that
those with low fasting HDL-C and high TAG concentrations had higher postprandial TAG [36]. It is
possible that men from our cohort were at a greater metabolic stress which may be a contributory
factor in the gender-specific effect of S447 genotype on the fasting and postprandial responses.
Previous studies have shown associations between the HindIII polymorphism and elevated
lipids [10]. In this study, we did not find any significant difference in fasting and postprandial lipid
levels across the genotypes of the polymorphism. However, the combination of HindIII and S447X
markers revealed significant associations with TAG and glucose AUC, which might be due to the
strong LD between the HindIII and S447X markers. In addition, previous studies have investigated the
effect of this polymorphism on postprandial lipids using only a single meal [15]. Hence, our finding
with HindIII polymorphism requires a replication using a sequential meal challenge, which reflects the
habitual eating pattern.
In conclusion, our study provides novel findings of an effect of LPL S447X polymorphism on the
postprandial glucose and gender-specific impact of the polymorphism on fasting and postprandial
TAG levels in response to sequential meal challenge in healthy participants. The elevated fasting and
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postprandial TAG and postprandial glucose and lower fasting HDL-C concentrations are likely to
result in prolonged appearance of lipids, in particular remnant particles, which might be one of the
reasons for the increased prevalence of CVD in participants carrying the S447 allele. Further studies
are required to confirm our gender-specific associations between the LPL polymorphism and fasting
and postprandial TAG levels with an assessment of serum LPL concentrations and activity using a
sequential meal challenge. This will further shed light on the size-effect of LPL polymorphisms on
lipid and glucose metabolism in population subgroups.
4. Experimental Section
4.1. Subjects
All individuals included in this study were obtained from postprandial studies using identical
inclusion/exclusion criteria, and all underwent the same sequential meal postprandial protocol, at
University of Reading between 1997 and 2007, as previously described [37]. Briefly, 261 participants
(109 women and 153 men) aged 22–71 years and BMI 17.6–37.3 kg/m2, were included in the dataset.
The postprandial study excluded participants who had CVD, including angina stroke; diabetes or
fasting glucose > 6.5 mmol/L, liver or other endocrine dysfunction; were pregnant or lactating; who
were smoking > 15 cigarette per day; doing aerobic exercise more than three times per week; who had
hemoglobin levels < 130g/L for men and 120g/L for women or taking medication or supplements.
The University of Reading Ethics and Research Committee and the West Berkshire Health Authority
Ethics Committees approved the experimental protocol. Informed consent to participate in the study
was obtained.
4.2. Sequential Test Meal Protocols
Details of the postprandial protocol have been described previously [37]. Briefly, study participants
were asked to refrain from alcohol or organised exercise regimens on the previous day and were
provided with a relatively low fat (<10 g fat) evening meal to standardise short-term fat intake. After a
12 h overnight fast, the participants were cannulated and fasting blood sample was taken. Following a
standard test breakfast (0 min; 3.9 MJ energy, 111 g carbohydrate, 19 g protein and 49 g fat) and lunch
(330 min; 2.3 MJ energy, 63 g carbohydrate, 15 g protein and 29 g fat), blood samples were taken from
the cannula at 30–60 min intervals until 480 min after the test breakfast.
4.3. Biochemical Measurements
Plasma glucose and lipid concentrations were measured using an automated analyzer assay
(Instrumentation Laboratory (UK) Ltd, Warrington, UK). In the fasting sample, HDL-C was estimated
in the supernatant following precipitation of the apolipoprotein B (apoB)-containing lipoproteins with
a dextran-manganese chloride reagent. The LDL-C concentration was calculated using the Friedewald
formula. Insulin levels were determined by ELISA (Dako Ltd, High Wycombe, UK). The total area
under the curve (AUC, 0–480 min) was calculated using the trapezium rule, and incremental area
under the curve (IAUC) calculated by subtracting the fasting levels from the total AUC. For NEFA,
AUC and IAUC were calculated from the time of suppression until the end of the postprandial period
(120–480 min) due to initial drop in NEFA concentrations after the meal. The homeostasis model
assessment of insulin resistance (HOMA-IR) was calculated using formula: [fasting insulin (pmol/L)
ˆ fasting glucose (mmol/L)]/135.
4.4. DNA Extraction and Genotyping
DNA was isolated from the buffy coat layer of 10 mL of EDTA blood using the Qiagen DNA
Blood Mini Kit (Qiagen Ltd, Crawley, UK). Allelic discrimination of two LPL gene polymorphisms
(rs320, HindIII and rs328, S447) was conducted using a “Assay-on-Demand” SNP genotyping assays
(Applied Biosystems, Warrington, UK).
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4.5. Statistical Analysis
The statistical significance of associations between biochemical data and genotypes was
established using a general linear model adjusted for covariates such as age, gender, and BMI, which
are highly correlated to lipid concentrations. Genotype distribution for LPL SNPs was assessed
using the Hardy-Weinberg equilibrium. Given the small number of rare homozygotes, we applied
a dominant model in which carriers of 1 or 2 copies of the minor allele of the two polymorphisms
HindIII and S447X were grouped and compared with major allele homozygotes. Interaction between
gender and polymorphisms on outcomes was examined by introducing the interaction terms into
the linear regression analysis models with adjustment to same variables in association test. All data
presented in the text and tables represents mean ˘ SD. We used SPSS software (version 21; SPSS Inc,
Chicago, IL, USA) for all statistical analyses. Probability values under 0.05 were considered significant.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/
17/3/397/s1.
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